In the global pharmaceutical industry, GMP compliance is not just a regulatory requirement—it’s the foundation of product safety and market access. For biotech and nutraceutical enterprises, non-compliant freeze-drying processes can lead to costly delays, batch rejections, and even market bans. Since 2009, Lyomac has been a trusted partner in navigating these complexities, delivering over 200 GMP/FDA/GAMP5-compliant freeze-drying systems across 15+ countries.
What makes Lyomac stand out in compliance? Every system is engineered with regulatory needs at its core: from 316L stainless steel contact surfaces to CIP/SIP integration, ensuring sterile processing. The GAMP5-certified SCADA control system automatically records and archives process data for 5+ years, simplifying audits with traceable, tamper-proof records. Our team of validation experts provides full documentation packages (IQ/OQ/PQ) and on-site support, guiding enterprises through every step of compliance—whether for FDA, EMA, or local regulatory bodies like India’s DCGI.
Beyond compliance, Lyomac’s freeze dryers balance precision and efficiency. With shelf temperature uniformity <±1°C and ultimate vacuum ≤1.0 Pa, they preserve thermosensitive ingredients (e.g., proteins, vaccines) with 98%+ activity retention. From laboratory-scale (12L) to industrial-grade (1000L) models, each system is customizable to meet unique URS requirements, supported by lifetime technical service and global spare parts supply.
For pharmaceutical companies aiming to expand globally, Lyomac delivers more than equipment—it delivers confidence. Choose a partner that turns compliance into a competitive advantage.
